<DOC>
	<DOCNO>NCT00192140</DOCNO>
	<brief_summary>- To describe proportion individual 5-49 year age shed vaccine strain virus . - To describe duration shed vaccine virus individual 5-49 year age . - To describe genotypic phenotypic stability shed vaccine virus . - To describe immune response FluMist individual 5-49 year age . - To describe safety FluMist individual 5-49 year age relation shed immune response</brief_summary>
	<brief_title>Trial Assess Shedding , Immunogenicity , Safety FluMist Administered Healthy Individuals 5-49 Years Age</brief_title>
	<detailed_description>The purpose study evaluate viral shedding , immunogenicity safety FluMist administer healthy individual 5-49 year age .</detailed_description>
	<criteria>549 year age ; In good health ; Individual parent/guardian available telephone ; Ability participant parent/guardian understand comply requirement protocol ; Signed informed consent HIPAA authorization participant parent/guardian . History hypersensitivity component FluMist , include egg egg product ; History hypersensitivity gentamicin ; Close contact immunocompromised within household ; Known suspect immune deficiency disease immunosuppressed alter compromise immune status consequence treatment immunosuppressive therapy ; History chronic underlie medical condition chronic disorder cardiovascular pulmonary system , chronic metabolic disease ( include diabetes ) , renal dysfunction , hemoglobinopathy ; History GuillainBarré syndrome ; History asthma reactive airway disease ; Acute febrile ( &gt; 100.0°F oral ) and/or respiratory illness , within 72 hour prior enrollment ; For child adolescent use aspirin aspirin contain product month prior enrollment anticipate use study ; Pregnancy , biologically capable woman ( e.g. , menses within last year ) , willing agree acceptable birth control three month enrol study ( biologically capable , urine pregnancy test must perform day vaccination negative result ) ; Administration intranasal medication within two week prior enrollment expect receipt study ; Administration live virus vaccine within one month prior enrollment receipt another live virus vaccine expect within one month vaccination study ; Administration inactivate vaccine within two week prior enrollment receipt another inactivate vaccine expect within two week vaccination study ; Participation another investigational trial administration investigational drug within one month prior enrollment study ; Employees research center , individual involve conduct study , family member individual ; Laboratory confirm influenza ( positive culture rapid antigen test ) prior influenza season ( 2003/2004 2004/2005 season ) ; Receipt influenza vaccine prior influenza season ; Any condition opinion investigator would interfere interpretation evaluation vaccine .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>